Search
Displaying 561–567 of 567 for “Retinitis pigmentosa”
-
The Foundation Fighting Blindness Presents the Emerging Science Showcase at OIS Retina 2018
Foundation NewsFour research and development leaders share the latest details of their groundbreaking work in therapies for retinal degenerative diseases.
-
Foundation News
Dr. Kelley brings more than 25 years of experience in developing, identifying, and advancing life science technologies to this leadership role at FFB
-
Foundation News
The primary goal of the landmark study, funded by the Foundation, is to provide companies and researchers with disease-progression data and potential clinical trial endpoints to drive therapy development
-
Foundation Fighting Blindness Announces Leadership Succession Plan After 45 Year Legacy
Foundation NewsDavid Brint has been elected Chairman, effective July 1, 2016. Brint succeeds co-founder and current Chairman, Gordon Gund, who will remain a member of the Board of Directors and will continue to be actively involved in the Foundation’s Research Oversight Committee
-
The Challenge Continues: FFB Chairman Gordon Gund is Interviewed on CNBC
In the PressIn a recent interview with CNBC’ s Brian Sullivan, during a tech-investor conference in Nantucket, Gordon explained why this is such a crucial time in retinal-research history.
-
FFB Chairman, Gordon Gund, Interviewed on Forbes.com
In the PressThe Foundation’s chairman and co-founder, Gordon Gund is interviewed on Forbes.com
-
Foundation Commits $2 Million to Development of a Cross-Cutting Drug Treatment
NewsMitoChem Therapeutics has identified three compounds that appear to boost mitochondrial function and, thus, show potential for slowing vision loss caused by a variety of retinal degenerations.
- Previous page
- page 1
- page 55
- page 56
- page 57
